These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 26968205)
21. Clinical trials with immunotherapy for high-grade glioma. Ruzevick J; Jackson C; Phallen J; Lim M Neurosurg Clin N Am; 2012 Jul; 23(3):459-70. PubMed ID: 22748658 [TBL] [Abstract][Full Text] [Related]
22. Immunotherapy for glioma: promises and challenges. Han SJ; Zygourakis C; Lim M; Parsa AT Neurosurg Clin N Am; 2012 Jul; 23(3):357-70. PubMed ID: 22748649 [TBL] [Abstract][Full Text] [Related]
23. Multi-omics study revealing the complexity and spatial heterogeneity of tumor-infiltrating lymphocytes in primary liver carcinoma. Shi L; Zhang Y; Feng L; Wang L; Rong W; Wu F; Wu J; Zhang K; Cheng S Oncotarget; 2017 May; 8(21):34844-34857. PubMed ID: 28422742 [TBL] [Abstract][Full Text] [Related]
24. Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic. Duong CP; Yong CS; Kershaw MH; Slaney CY; Darcy PK Mol Immunol; 2015 Oct; 67(2 Pt A):46-57. PubMed ID: 25595028 [TBL] [Abstract][Full Text] [Related]
25. Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model. Grauer OM; Sutmuller RP; van Maren W; Jacobs JF; Bennink E; Toonen LW; Nierkens S; Adema GJ Int J Cancer; 2008 Apr; 122(8):1794-802. PubMed ID: 18076066 [TBL] [Abstract][Full Text] [Related]
26. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma. Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of dendritic cell vaccines for patients with glioblastoma: A meta-analysis of randomized controlled trials. Lv L; Huang J; Xi H; Zhou X Int Immunopharmacol; 2020 Jun; 83():106336. PubMed ID: 32213460 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms of immunomodulation in human glioblastoma. Avril T; Vauleon E; Tanguy-Royer S; Mosser J; Quillien V Immunotherapy; 2011 Apr; 3(4 Suppl):42-4. PubMed ID: 21524170 [TBL] [Abstract][Full Text] [Related]
34. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756 [TBL] [Abstract][Full Text] [Related]
35. Armed hunter killers: discerning the role of adoptive T-cell transfer for glioblastoma. Samaha H; El Naggar S; Ahmed N Immunotherapy; 2015; 7(5):481-5. PubMed ID: 26065474 [No Abstract] [Full Text] [Related]
36. A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma. Chang CN; Huang YC; Yang DM; Kikuta K; Wei KJ; Kubota T; Yang WK J Clin Neurosci; 2011 Aug; 18(8):1048-54. PubMed ID: 21715171 [TBL] [Abstract][Full Text] [Related]
37. [Experimental studies on the antitumor activity of glioma-infiltrating lymphocytes against autologous glioma]. Li Y Zhonghua Yi Xue Za Zhi; 1992 May; 72(5):284-6, 319. PubMed ID: 1327462 [TBL] [Abstract][Full Text] [Related]
38. [Current Cancer Immunotherapy Using Activated Lymphocytes - Do Lymphocytes Actually Recognize Cancer Cells ?]. Yamaguchi Y; Katata Y; Okawaki M; Yamamura M; Sawaki A Gan To Kagaku Ryoho; 2015 Sep; 42(9):1031-5. PubMed ID: 26469157 [TBL] [Abstract][Full Text] [Related]
39. Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients. Nava S; Lisini D; Pogliani S; Dossena M; Bersano A; Pellegatta S; Parati E; Finocchiaro G; Frigerio S Stem Cells Transl Med; 2015 Oct; 4(10):1164-72. PubMed ID: 26273063 [TBL] [Abstract][Full Text] [Related]
40. Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells. Berger TG; Haendle I; Schrama D; Lüftl M; Bauer N; Pedersen LØ; Schuler-Thurner B; Hohenberger W; Straten Pt Pt; Schuler G; Becker JC Int J Cancer; 2004 Aug; 111(2):229-37. PubMed ID: 15197776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]